wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39257661-BFCD5F94-7FFF-4855-AFDB-E6797F699B62
Q39257661-BFCD5F94-7FFF-4855-AFDB-E6797F699B62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39257661-BFCD5F94-7FFF-4855-AFDB-E6797F699B62
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
P356
Q39257661-BFCD5F94-7FFF-4855-AFDB-E6797F699B62
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39257661-BFCD5F94-7FFF-4855-AFDB-E6797F699B62
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc27c8791652eea7b96b701376d52e675c67d841
P356
10.2217/FON.13.250
http://www.w3.org/2001/XMLSchema#string
P356
FON.13.250